SCHEMBL880116

SCHEMBL880116

COBNCC(O)(c1ccc(Cl)cc1)c1ccc(I)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 8/20 0.49
HTT P42858 7/20 0.46
LMNA P02545 6/20 0.46
MEN1 O00255 6/20 0.44
KMT2A Q03164 6/20 0.44
SMN1; SMN2 Q16637 5/20 0.44
L3MBTL1 Q9Y468 3/20 0.44
POLB P06746 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
RECQL P46063 1/20 0.43
GAA P10253 1/20 0.42
MAPK1 P28482 2/20 0.39
XBP1 P17861 1/20 0.39
BCL2 P10415 2/20 0.37
GRIN2D O15399 1/20 0.34
GRIN3B O60391 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12157315 0.79 NPSR1 (0.57) NPSR1HTTLMNAMEN1KMT2A
SCHEMBL880118 0.77 AKT1 (0.62) NPSR1PRKACAAKT1AKT2AKT3
SCHEMBL13327374 0.74 NPSR1 (0.51) NPSR1HTTLMNAMEN1KMT2A
SCHEMBL12157320 0.73 NPSR1 (0.49) NPSR1HTTLMNAMEN1KMT2A
SCHEMBL1978581 0.72 SMN1; SMN2 (0.59) NPSR1HTTLMNAMEN1KMT2A
SCHEMBL851695 0.71 NPSR1 (0.49) NPSR1HTTLMNAMEN1KMT2A
SCHEMBL851652 0.70 PRKACA (0.53) NPSR1HTTLMNAMEN1KMT2A
SCHEMBL851562 0.70 PRKACA (0.53) NPSR1HTTLMNAMEN1KMT2A
SCHEMBL851350 0.70 PRKACA (0.53) NPSR1HTTLMNAMEN1KMT2A
SCHEMBL13539406 0.69 NPSR1 (0.67) NPSR1HTTLMNAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2433632-A1 Compositions and combinations comprising non-racemic 2-amino-1-(4-chloro-phenyl)-1-[4-(1H-pyrazol-4-yl)-phenyl]-ethanol, for use in medicine Astex Therapeutics Limited (GB) 2012-03-28 EP disclosed
WO-2008110846-A2 COMPOSITIONS COMPRISING (S)-2-AMINO-1-(4-CHLOROPHENYL)-1-[4-(1H-PYRAZOL-4-YL)-PHENYL]-ETHANOL AS MODULATOR OF PROTEIN KINASES ASTEX THERAPEUTICS LIMITED (GB) 2008-09-18 WO disclosed